Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000412308 | SCV000486979 | likely pathogenic | Ataxia-telangiectasia syndrome | 2016-09-15 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000412308 | SCV001374576 | pathogenic | Ataxia-telangiectasia syndrome | 2019-06-06 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in ATM are known to be pathogenic (PMID: 23807571, 25614872). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site, but this prediction has not been confirmed by published transcriptional studies. This variant has not been reported in the literature in individuals with ATM-related conditions. ClinVar contains an entry for this variant (Variation ID: 371408). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Ile709Leufs*26) in the ATM gene. It is expected to result in an absent or disrupted protein product. |